Money Today reporter Kim Geon-woo | 05.02.2024 09:57 Cellivery announced on the 5th that the research and development results of “CP-BMP2”, a bone formation promoter incorporating TSDT (drug transfer technology), were published in “Materials Today Bio”, an academic journal international in the field of biomaterials. . CP-BMP2, which Cellivery is developing, is a bio-better treatment […]
The post Successful Development of CP-BMP2: A Game-Changer in Fracture Treatment appeared first on News Directory 3.